Monday, December 09, 2019 3:14:43 PM
Remember back on 7MAY19 -
https://www.globenewswire.com/news-release/2019/05/07/1818383/0/en/GREATER-CANNABIS-COMPANY-PARTNERS-WITH-SYMTOMAX-TO-EXPAND-ACROSS-EUROPE-THE-MIDDLE-EAST-AND-AFRICA.html
Effective immediately, Symtomax will distribute on a white-label basis Greater Cannabis Company’s oral eluting patch, transdermal patch, and other proprietary technologies and products across its distribution network that spans across Europe, the Middle East and Africa. Additional geographic and product expansion plans are expected to be added as the two companies begin implementing the initial phases of this agreement.
https://www.globenewswire.com/news-release/2019/05/07/1818383/0/en/GREATER-CANNABIS-COMPANY-PARTNERS-WITH-SYMTOMAX-TO-EXPAND-ACROSS-EUROPE-THE-MIDDLE-EAST-AND-AFRICA.html
My posts are my opinion. Always trade at your own risk.
Recent GCAN News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:22:05 PM
- GCANRx Announces Relisting To OTCQB Market Tier • GlobeNewswire Inc. • 12/03/2025 12:45:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/16/2025 03:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2025 11:00:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:05:11 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/08/2025 01:56:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 03:57:40 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 05/06/2025 12:54:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/05/2025 10:09:45 AM
